Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma
Blood Cancer J
.
2012 Aug 31;2(8):e85.
doi: 10.1038/bcj.2012.33.
Authors
V Grossmann
1
,
U Bacher
,
V Artusi
,
A Kohlmann
,
N Nadarajah
,
W Kern
,
S Schnittger
,
T Haferlach
,
C Haferlach
Affiliation
1
MLL Munich Leukemia Laboratory GmbH, Munich, Germany.
PMID:
22941340
PMCID:
PMC3432486
DOI:
10.1038/bcj.2012.33
No abstract available